Capstone Therapeutics Corp Retirement Plan
Investment Model Portfolios
This plan is created upon a user's request.
Investment options of Capstone Therapeutics Corp Retirement Plan
Total Available Funds: 25
| Asset Class |
Ticker
| Description |
| US EQUITY |
|
|
| LARGE BLEND |
FFIDX |
Fidelity |
| LARGE GROWTH |
FDCAX |
Fidelity Capital Appreciation |
| Small Growth |
FDSCX |
Fidelity Stock Selector Sm Cp |
| Mid-Cap Growth |
FMCSX |
Fidelity Mid-Cap Stock |
| LARGE GROWTH |
JARTX |
Janus Forty S |
| Mid-Cap Growth |
BGRFX |
Baron Growth |
| Mid-Cap Growth |
STCSX |
Wells Fargo Advantage Common Stock Inv |
| MID-CAP VALUE |
LMCPX |
Lord Abbett Mid-Cap Value P |
| LARGE VALUE |
EHSTX |
Eaton Vance Large-Cap Value A |
|
| INTERNATIONAL EQUITY |
|
|
| Foreign Large Blend |
FDIVX |
Fidelity Diversified International |
|
| Others |
|
|
| Health |
FSMEX |
Fidelity Select Medical Equip & Systems |
| ROOT |
CASH |
FRTXX (Money Market) |
| Retirement Income |
FFFAX |
Fidelity Freedom Income |
| Target Date 2000-2010 |
FFFBX |
Fidelity Freedom 2000 |
| Target Date 2000-2010 |
FFFCX |
Fidelity Freedom 2010 |
| Target Date 2016-2020 |
FFFDX |
Fidelity Freedom 2020 |
| Target Date 2026-2030 |
FFFEX |
Fidelity Freedom 2030 |
| Target Date 2036-2040 |
FFFFX |
Fidelity Freedom 2040 |
| Target Date 2000-2010 |
FFFVX |
Fidelity Freedom 2005 |
| Target Date 2011-2015 |
FFVFX |
Fidelity Freedom 2015 |
| Target Date 2021-2025 |
FFTWX |
Fidelity Freedom 2025 |
| Target Date 2031-2035 |
FFTHX |
Fidelity Freedom 2035 |
| Target Date 2041-2045 |
FFFGX |
Fidelity Freedom 2045 |
| Target Date 2050+ |
FFFHX |
Fidelity Freedom 2050 |
|
| FIXED INCOME |
|
|
| Intermediate-Term Bond |
FBIDX |
Fidelity US Bond Index |
|
Investment model portfolios
We provide two types of investment model portfolios for Capstone Therapeutics Corp Retirement Plan participants. You can customize and follow a model portfolio in your plan account.
Types of portfolio strategies
- Strategic asset allocation portfolio: It invests in a diversified portfolio of multiple assets, buy-and-hold without frequently changing the asset allocation weights.
- Suitable: For long-term (more than 15 years, preferably more than 20 years), want to be tax efficient and can withstand interim drawdown or loss as high as 50% or more.
- Pros:
- Less error-prone
- Infrequent rebalancing or transactions
- Tax efficient for taxable brokerage investments
- Cons:
- Interim loss or drawdown can be substantial
- Possible low returns for an extended period, such as 10 years or longer
- Tactical asset allocation portfolio: it invests in a diversified portfolio of multiple assets, dynamically adjust stock and bond allocations to minimize losses during market stress.
- Suitable: For long-term (more than 10 years or preferably longer) capital. Investors are willing to rebalance as frequent as monthly.
- Pros:
- Reduce large interim loss or drawdown
- Less sensitive to investment entry point
- Likely to improve returns
- Cons
- Demand more frequent rebalancing or transactions
- Less tax efficient — more suitable in a tax-deferred account such as 401(k) or IRA
- Can experience a period of lower returns compared to a broad-based strategic allocation or a buy-and-hold benchmark, especially in some bull markets
These portfolios are proactively monitored and rebalanced on a monthly basis when needed, ensuring it remains in line with its target allocation.
Let us know (Email us) if you need help to create a custom model portfolio for your plan.
Example model portfolios
The following provides historical returns for example model portfolios with a moderate risk profile (at most 60% in stocks) and their comparison with benchmark index funds. You can customize these portfolios according to your own risk profile.
Strategic Asset Allocation Model Portfolio
The following portfolio is based on the MyPlanIQ Strategic Asset Allocation (SAA) strategy.
Tactical Asset Allocation Model Portfolio
The following portfolio is based on the MyPlanIQ Tactical Asset Allocation (TAA) strategy.
|
Ticker/Portfolio |
Last 1 Week |
1 Yr |
3 Yr |
5 Yr |
10 Yr |
15 Yr |
20 Yr |
Inception |
YTD |
2024 |
2023 |
2022 |
2021 |
2020 |
2019 |
2018 |
2017 |
2016 |
2015 |
2014 |
2013 |
2012 |
2011 |
2010 |
2009 |
2008 |
2007 |
2006 |
2005 |
2004 |
2003 |
2002 |
2001 |
2000 |
1999 |
1998 |
1997 |
1996 |
1995 |
1994 |
1993 |
1992 |
1991 |
1990 |
1989 |
1988 |
1987 |
1986 |
1985 |
1984 |
1983 |
1982 |
1981 |
1980 |
1979 |
|
Annualized Return (%)
|
Capstone Ther... Moderate
|
-1.15 |
-3.46 |
0.03 |
4.98 |
4.07 |
5.40 |
5.81 |
6.22 |
NA |
3.23 |
8.03 |
-17.90 |
8.38 |
23.04 |
26.02 |
-6.33 |
6.86 |
5.02 |
0.03 |
2.31 |
15.55 |
4.78 |
1.04 |
6.93 |
12.27 |
-1.49 |
11.07 |
11.48 |
4.52 |
9.16 |
17.02 |
2.87 |
6.01 |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
|
VFINX (VANGUA...R SHARES)
|
-1.25 |
9.98 |
9.75 |
10.95 |
11.06 |
12.38 |
9.19 |
7.54 |
NA |
24.84 |
26.12 |
-18.24 |
28.53 |
18.74 |
31.33 |
-4.55 |
21.66 |
11.83 |
1.23 |
13.52 |
32.17 |
15.82 |
1.96 |
14.91 |
26.52 |
-37.02 |
5.39 |
15.64 |
4.77 |
10.74 |
28.50 |
-22.17 |
-12.03 |
-9.05 |
21.08 |
28.62 |
33.18 |
22.87 |
37.45 |
1.18 |
10.15 |
8.24 |
32.05 |
-3.33 |
28.37 |
14.92 |
3.97 |
9.30 |
22.60 |
3.67 |
17.07 |
19.25 |
-8.55 |
27.89 |
-2.07 |
|
VSMGX (VANGUA...R SHARES)
|
-0.67 |
6.25 |
1.68 |
4.40 |
4.69 |
6.67 |
5.54 |
5.08 |
NA |
10.28 |
15.51 |
-16.01 |
10.08 |
13.59 |
19.30 |
-6.28 |
14.86 |
7.09 |
-2.21 |
6.38 |
14.73 |
9.78 |
0.12 |
13.14 |
20.35 |
-26.49 |
7.21 |
13.30 |
5.68 |
11.76 |
22.40 |
-10.34 |
-4.78 |
1.27 |
14.09 |
21.59 |
17.90 |
10.77 |
26.58 |
2.04 |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
|
Sharpe Ratio
|
Capstone Ther... Moderate
|
NA |
0.52 |
-0.17 |
0.49 |
0.41 |
NA |
NA |
0.63 |
NA |
0.28 |
0.35 |
-1.65 |
0.56 |
1.23 |
2.34 |
-0.96 |
1.20 |
1.05 |
0.00 |
0.33 |
2.39 |
0.82 |
0.14 |
0.61 |
1.51 |
-0.56 |
0.86 |
1.03 |
0.40 |
1.14 |
2.97 |
0.47 |
0.99 |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
|
VFINX (VANGUA...R SHARES)
|
NA |
0.60 |
0.95 |
0.80 |
0.65 |
NA |
NA |
0.45 |
0.51 |
1.67 |
1.73 |
-0.82 |
2.17 |
0.53 |
2.39 |
-0.35 |
3.16 |
0.89 |
0.08 |
1.19 |
2.90 |
1.25 |
0.08 |
0.82 |
0.97 |
-0.92 |
0.14 |
1.22 |
0.24 |
0.88 |
1.63 |
-0.90 |
-0.68 |
-0.60 |
0.97 |
1.23 |
1.61 |
1.62 |
4.31 |
-0.19 |
0.90 |
0.57 |
1.91 |
-0.55 |
1.71 |
0.59 |
-0.01 |
0.30 |
1.47 |
-0.26 |
0.79 |
0.63 |
-1.30 |
1.17 |
-3.84 |
|
VSMGX (VANGUA...R SHARES)
|
NA |
0.62 |
0.74 |
0.50 |
0.48 |
NA |
NA |
0.51 |
0.88 |
0.87 |
1.45 |
-1.22 |
1.32 |
0.70 |
2.77 |
-0.87 |
3.75 |
0.83 |
-0.26 |
1.01 |
2.16 |
1.23 |
0.01 |
1.18 |
1.12 |
-0.98 |
0.39 |
1.34 |
0.49 |
1.49 |
2.09 |
-0.75 |
-0.59 |
-0.24 |
1.06 |
1.56 |
1.56 |
0.91 |
4.18 |
4.60 |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
|
Standard Deviation(%)
|
Capstone Ther... Moderate
|
NA |
10.99 |
12.33 |
13.65 |
10.56 |
NA |
NA |
8.73 |
NA |
10.56 |
10.65 |
11.66 |
14.82 |
18.61 |
10.51 |
7.97 |
5.21 |
4.56 |
5.00 |
6.88 |
6.50 |
5.75 |
7.47 |
11.14 |
8.08 |
4.31 |
9.44 |
7.97 |
5.95 |
7.18 |
5.50 |
3.73 |
3.75 |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
|
VFINX (VANGUA...R SHARES)
|
NA |
19.74 |
17.13 |
17.38 |
18.46 |
NA |
NA |
18.09 |
23.24 |
12.67 |
13.09 |
24.19 |
13.11 |
34.69 |
12.48 |
17.11 |
6.68 |
13.11 |
15.51 |
11.39 |
11.07 |
12.74 |
23.36 |
18.07 |
27.22 |
40.99 |
16.02 |
10.04 |
10.29 |
11.10 |
17.04 |
25.96 |
21.55 |
22.20 |
18.17 |
20.48 |
18.21 |
11.77 |
7.77 |
9.92 |
8.83 |
9.93 |
14.69 |
16.06 |
13.09 |
17.07 |
33.80 |
16.55 |
11.67 |
12.80 |
13.62 |
18.09 |
14.61 |
16.53 |
23.80 |
|
VSMGX (VANGUA...R SHARES)
|
NA |
10.45 |
10.08 |
10.06 |
10.41 |
NA |
NA |
11.48 |
11.95 |
7.69 |
8.26 |
14.34 |
7.62 |
19.08 |
6.43 |
8.81 |
3.80 |
8.31 |
8.51 |
6.28 |
6.80 |
7.99 |
14.68 |
11.10 |
18.01 |
27.95 |
10.37 |
7.43 |
6.96 |
7.25 |
10.38 |
15.37 |
12.42 |
12.30 |
10.07 |
11.65 |
9.10 |
7.74 |
5.41 |
15.57 |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
|
Draw Down(%)
|
Capstone Ther... Moderate
|
NA |
11.22 |
25.26 |
25.26 |
25.26 |
NA |
NA |
25.26 |
NA |
2.11 |
11.22 |
19.48 |
8.56 |
20.50 |
6.31 |
12.65 |
5.05 |
4.43 |
3.94 |
5.26 |
4.64 |
5.06 |
6.42 |
9.99 |
4.69 |
7.20 |
7.09 |
9.86 |
4.87 |
6.79 |
3.13 |
4.40 |
2.54 |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
|
VFINX (VANGUA...R SHARES)
|
NA |
18.76 |
18.76 |
24.59 |
33.83 |
NA |
NA |
55.25 |
18.76 |
8.45 |
9.97 |
24.59 |
5.14 |
33.83 |
6.63 |
19.40 |
2.60 |
10.29 |
12.05 |
7.30 |
5.59 |
9.60 |
18.71 |
15.66 |
27.17 |
47.73 |
9.88 |
7.47 |
7.01 |
7.47 |
13.79 |
33.02 |
29.18 |
16.55 |
11.81 |
19.20 |
10.79 |
7.45 |
2.50 |
8.48 |
4.84 |
5.63 |
5.57 |
19.19 |
7.35 |
7.24 |
33.08 |
11.63 |
7.51 |
10.58 |
7.02 |
13.21 |
15.61 |
16.03 |
2.40 |
|
VSMGX (VANGUA...R SHARES)
|
NA |
9.62 |
12.88 |
22.29 |
22.43 |
NA |
NA |
41.18 |
9.62 |
4.17 |
8.15 |
21.74 |
3.53 |
22.43 |
3.12 |
11.47 |
1.14 |
6.20 |
8.34 |
4.70 |
5.67 |
6.27 |
12.90 |
8.64 |
19.61 |
36.81 |
6.11 |
6.13 |
4.74 |
5.89 |
8.91 |
20.06 |
17.93 |
8.77 |
6.26 |
11.99 |
6.02 |
4.75 |
1.82 |
1.89 |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
|
Yield(%)
|
Capstone Ther... Moderate
|
NA |
4.86 |
4.74 |
4.45 |
3.75 |
NA |
NA |
3.60 |
NA |
0.00 |
5.10 |
2.05 |
7.11 |
4.03 |
4.25 |
3.60 |
0.11 |
3.46 |
1.74 |
6.46 |
4.65 |
3.04 |
2.68 |
2.38 |
2.57 |
2.66 |
4.52 |
5.25 |
3.19 |
2.25 |
3.37 |
3.20 |
5.07 |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
|
VFINX (VANGUA...R SHARES)
|
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
|
VSMGX (VANGUA...R SHARES)
|
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
Data as of 10/31/2023, AR inception is 12/31/2000
